Understanding racial disparities in health care expenditures for cervical cancer.

IF 2.3 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Jerusha Daggolu, Marjan Zakeri, Sujit Sansgiry
{"title":"Understanding racial disparities in health care expenditures for cervical cancer.","authors":"Jerusha Daggolu, Marjan Zakeri, Sujit Sansgiry","doi":"10.18553/jmcp.2024.30.8.873","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cervical cancer demonstrates a notable efficacy in treatment, evidenced by a 92% 5-year survival rate among cases diagnosed at a localized stage. In 2020, the estimated annual national expenditure for cervical cancer care amounted to $2.3 billion in the United States. Limited real-world data are available for racial disparities in health care expenditures for cervical cancer.</p><p><strong>Objective: </strong>To evaluate racial disparities associated with annual health care expenditures among patients diagnosed with cervical cancer in the United States.</p><p><strong>Methods: </strong>A retrospective observational cohort study of annual health care expenditures in patients with cervical cancer diagnosed during 2014-2019 was performed using the Medical Expenditure Panel Survey data. In addition to the descriptive weighted analysis, an unadjusted analysis of the annual health care expenditure was conducted. An adjusted linear regression model with log transformation of the outcome variable was used to evaluate the total annual health care expenditure as well as expenditures by category across the racial groups.</p><p><strong>Results: </strong>Overall, 826 patients with cervical cancer were identified from the Medical Expenditure Panel Survey during 2014-2019. The majority were classified as White patients (81.2%) and in the age group of 45-64 years (44.65%). On average, the total annual health care expenditure was $11,537 (95% CI = $9,887-$13,186) among the White cohort, $10,659 (95% CI = $6,704-$14,614) among the African American cohort, and $8,726 (95% CI = $6,113-$11,340) among the Hispanic cohort. After adjusting for covariates, the average total annual health care expenditure for the Hispanic cohort was 35% of the total health care expenditure of the White cohort (<i>P</i> < 0.001) and 46% of the African American cohort's health care expenditure (<i>P</i> = 0.02). Specifically, adjusted costs of office-based and outpatient visits for the Hispanic cohort were 47% (<i>P</i> = 0.009) and 57% (<i>P</i> = 0.005) lower than for the White cohort, respectively. The total annual home health care expenditure for the African American cohort was 49% lower than White patients (<i>P</i> = <i>0.03</i>), and the Hispanic cohort's total expenditure, excluding prescription medicines, was 57% lower than African American patients (<i>P</i> = 0.02).</p><p><strong>Conclusions: </strong>This study provides valuable information regarding the health care disparities that need to be addressed among certain minority races. Reducing the disparities in health care spending across racial groups should be included as a crucial element in tackling well-established health care inequities.</p>","PeriodicalId":16170,"journal":{"name":"Journal of managed care & specialty pharmacy","volume":"30 8","pages":"873-881"},"PeriodicalIF":2.3000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11293762/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of managed care & specialty pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18553/jmcp.2024.30.8.873","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cervical cancer demonstrates a notable efficacy in treatment, evidenced by a 92% 5-year survival rate among cases diagnosed at a localized stage. In 2020, the estimated annual national expenditure for cervical cancer care amounted to $2.3 billion in the United States. Limited real-world data are available for racial disparities in health care expenditures for cervical cancer.

Objective: To evaluate racial disparities associated with annual health care expenditures among patients diagnosed with cervical cancer in the United States.

Methods: A retrospective observational cohort study of annual health care expenditures in patients with cervical cancer diagnosed during 2014-2019 was performed using the Medical Expenditure Panel Survey data. In addition to the descriptive weighted analysis, an unadjusted analysis of the annual health care expenditure was conducted. An adjusted linear regression model with log transformation of the outcome variable was used to evaluate the total annual health care expenditure as well as expenditures by category across the racial groups.

Results: Overall, 826 patients with cervical cancer were identified from the Medical Expenditure Panel Survey during 2014-2019. The majority were classified as White patients (81.2%) and in the age group of 45-64 years (44.65%). On average, the total annual health care expenditure was $11,537 (95% CI = $9,887-$13,186) among the White cohort, $10,659 (95% CI = $6,704-$14,614) among the African American cohort, and $8,726 (95% CI = $6,113-$11,340) among the Hispanic cohort. After adjusting for covariates, the average total annual health care expenditure for the Hispanic cohort was 35% of the total health care expenditure of the White cohort (P < 0.001) and 46% of the African American cohort's health care expenditure (P = 0.02). Specifically, adjusted costs of office-based and outpatient visits for the Hispanic cohort were 47% (P = 0.009) and 57% (P = 0.005) lower than for the White cohort, respectively. The total annual home health care expenditure for the African American cohort was 49% lower than White patients (P = 0.03), and the Hispanic cohort's total expenditure, excluding prescription medicines, was 57% lower than African American patients (P = 0.02).

Conclusions: This study provides valuable information regarding the health care disparities that need to be addressed among certain minority races. Reducing the disparities in health care spending across racial groups should be included as a crucial element in tackling well-established health care inequities.

了解宫颈癌医疗支出中的种族差异。
背景:宫颈癌的治疗效果显著,在局部阶段确诊的病例中,5 年生存率高达 92%。据估计,2020 年美国每年用于宫颈癌治疗的国家支出达 23 亿美元。有关宫颈癌医疗支出的种族差异的真实世界数据有限:评估美国确诊宫颈癌患者每年医疗支出的种族差异:利用医疗支出小组调查数据,对 2014-2019 年期间确诊的宫颈癌患者的年度医疗支出进行了一项回顾性观察队列研究。除描述性加权分析外,还对年度医疗支出进行了未调整分析。使用对结果变量进行对数变换的调整线性回归模型来评估不同种族群体的年度医疗支出总额以及不同类别的支出:2014-2019年期间,医疗支出小组调查共确定了826名宫颈癌患者。大部分患者为白人(81.2%),年龄在 45-64 岁之间(44.65%)。平均而言,白人队列中的年度医疗保健总支出为 11,537 美元(95% CI = 9,887 美元-13,186 美元),非裔美国人队列中的年度医疗保健总支出为 10,659 美元(95% CI = 6,704 美元-14,614 美元),西班牙裔队列中的年度医疗保健总支出为 8,726 美元(95% CI = 6,113 美元-11,340 美元)。在对协变量进行调整后,西班牙裔人群的平均年度医疗保健总支出是白人人群医疗保健总支出的 35% (P < 0.001),是非裔美国人人群医疗保健总支出的 46% (P = 0.02)。具体而言,西班牙裔人群的调整后诊室和门诊费用分别比白人人群低 47% (P = 0.009) 和 57% (P = 0.005)。非裔美国人队列的年度家庭医疗保健总支出比白人患者低 49% (P = 0.03),而西班牙裔队列的总支出(不包括处方药)比非裔美国人患者低 57% (P = 0.02):这项研究提供了有关某些少数民族需要解决的医疗差距问题的宝贵信息。缩小不同种族群体之间的医疗支出差距,应作为解决公认的医疗不公平问题的关键因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of managed care & specialty pharmacy
Journal of managed care & specialty pharmacy Health Professions-Pharmacy
CiteScore
3.50
自引率
4.80%
发文量
131
期刊介绍: JMCP welcomes research studies conducted outside of the United States that are relevant to our readership. Our audience is primarily concerned with designing policies of formulary coverage, health benefit design, and pharmaceutical programs that are based on evidence from large populations of people. Studies of pharmacist interventions conducted outside the United States that have already been extensively studied within the United States and studies of small sample sizes in non-managed care environments outside of the United States (e.g., hospitals or community pharmacies) are generally of low interest to our readership. However, studies of health outcomes and costs assessed in large populations that provide evidence for formulary coverage, health benefit design, and pharmaceutical programs are of high interest to JMCP’s readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信